Gaceta medica de Mexico · 2025
Baseline brain magnetic resonance imaging findings as predictors of dementia progression: insights from a Mexican memory clinic.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Martínez-Bravo Luis E, Aguilar-Navarro Sara G, Vazquez-Guajardo Mauricio, Gutiérrez-Gutiérrez Lidia A, Juarez-Cedillo Teresa, Mimenza-Alvarado Alberto J
Аннотация
BACKGROUND: Dementia is a progressive syndrome characterized by cognitive decline. Brain atrophy has been associated with disease progression, but its predictive value in Latin American populations remains underexplored.
OBJECTIVE: To assess whether brain atrophy, evaluated through visual rating scales, predicts progression from mild to moderate dementia over one year, using the Clinical Dementia Rating-Sum of Boxes.
MATERIALS AND METHODS: A retrospective cohort study was conducted in a memory clinic with 73 participants aged ≥65 years with mild dementia and baseline brain magnetic resonance imaging. Temporal and parietal atrophy were assessed using Scheltens and Koedam scales, and white matter hyperintensities were evaluated with Fazekas. Logistic regression models adjusted for age, education, depression, and vitamin D/B12 deficiencies were used to estimate the risk of progression.
RESULTS: Fifteen participants (21%) progressed to moderate dementia. Moderate-to-severe atrophy in the parietal (OR: 6.84; 95%CI: 1.29-36.2; p = 0.024) and temporal lobes (OR: 6.33; 95%CI: 1.23-32.43; p = 0.027) significantly increased the odds of progression.
CONCLUSIONS: At one-year follow-up, moderate-to-severe atrophy in the parietal and temporal lobes was associated with dementia progression, supporting the potential clinical utility of visual rating scales for monitoring disease progression.
OBJECTIVE: To assess whether brain atrophy, evaluated through visual rating scales, predicts progression from mild to moderate dementia over one year, using the Clinical Dementia Rating-Sum of Boxes.
MATERIALS AND METHODS: A retrospective cohort study was conducted in a memory clinic with 73 participants aged ≥65 years with mild dementia and baseline brain magnetic resonance imaging. Temporal and parietal atrophy were assessed using Scheltens and Koedam scales, and white matter hyperintensities were evaluated with Fazekas. Logistic regression models adjusted for age, education, depression, and vitamin D/B12 deficiencies were used to estimate the risk of progression.
RESULTS: Fifteen participants (21%) progressed to moderate dementia. Moderate-to-severe atrophy in the parietal (OR: 6.84; 95%CI: 1.29-36.2; p = 0.024) and temporal lobes (OR: 6.33; 95%CI: 1.23-32.43; p = 0.027) significantly increased the odds of progression.
CONCLUSIONS: At one-year follow-up, moderate-to-severe atrophy in the parietal and temporal lobes was associated with dementia progression, supporting the potential clinical utility of visual rating scales for monitoring disease progression.